Literature DB >> 15525829

Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.

Kyoji Okada1, Tadashi Hasegawa, Jun Nishida, Akira Ogose, Takahiro Tajino, Toshihisa Osanai, Michiro Yanagisawa, Masahito Hatori.   

Abstract

BACKGROUND: The clinicopathologic profile and prognostic factors of osteosarcomas after the age of 50 years have been obscure.
METHODS: Clinicopathologic features were analyzed in 645 patients with osteosarcoma who were registered at the Tohoku Musculoskeletal Tumor Society and National Cancer Center in Tokyo between 1972 and 2002.
RESULTS: Sixty-four patients (9.9%; 34 men and 30 women) were more than 50 years old. The most common location was the distal femur (n = 13), followed by the pelvis (n = 10), proximal femur (n = 9), and proximal fibula (n = 6). Seven (11%) patients had lung metastasis at initial presentation. On radiographs, an osteolytic appearance without periosteal reactions was a common and characteristic feature. Forty-eight tumors (75%) were classified as conventional osteosarcomas. Fourteen cases (22%) were secondary; postradiation osteosarcoma was most common in these patients, but there was no Paget's sarcoma. At the initial presentation, misdiagnoses without biopsy were made in 15 (23%) of the 64 cases. Preoperative chemotherapy was given to 22 patients, but the effect was poor in 18 cases (82%). Fifty-four patients underwent surgery, whereas the other 10 patients were treated without surgery because of systemic or inoperable local conditions. The overall survival rate at 5 years was 55.5%. Multivariate analysis showed initial pulmonary metastasis, axial tumor location, and larger tumors as significant prognostic factors.
CONCLUSIONS: In northern Japan, most patients with osteosarcoma after the age of 50 had primary osteosarcoma. Careful radiological examination and biopsy are mandatory for correct diagnosis. Current systemic chemotherapy is not effective for this age group. Alternative treatment strategies should be considered.

Entities:  

Mesh:

Year:  2004        PMID: 15525829     DOI: 10.1245/ASO.2004.03.004

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  14 in total

1.  Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison.

Authors:  Tracy A Marko; Brandon J Diessner; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2016-02-29       Impact factor: 3.167

Review 2.  Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.

Authors:  Rajendra Kumar; Meena Kumar; Kavin Malhotra; Shreyaskumar Patel
Journal:  Curr Oncol Rep       Date:  2018-02-28       Impact factor: 5.075

3.  Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Hiroyuki Nagasawa; Naohisa Miyakoshi; Yasutaka Murahashi; Junya Shimizu; Emi Mizushima; Toshihiko Yamashita; Yoichi Shimada
Journal:  Med Princ Pract       Date:  2019-04-17       Impact factor: 1.927

4.  Survival analysis of elderly patients with osteosarcoma.

Authors:  Yoshinori Imura; Satoshi Takenaka; Shigeki Kakunaga; Takaaki Nakai; Toru Wakamatsu; Hidetatsu Outani; Takaaki Tanaka; Hironari Tamiya; Kazuya Oshima; Kenichiro Hamada; Norifumi Naka; Nobuhito Araki; Ikuo Kudawara; Takafumi Ueda; Hideki Yoshikawa
Journal:  Int Orthop       Date:  2019-04-22       Impact factor: 3.075

5.  Primary osteosarcoma in patients older than 40 years of age.

Authors:  Dae Geun Jeon; Soo Yong Lee; Wan Hyung Cho; Won Seok Song; Jong Hoon Park
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

6.  Relationships between plain-film radiographic patterns and clinicopathologic variables in AJCC stage II osteosarcoma.

Authors:  Min Suk Kim; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jae-Soo Koh; Jun Ah Lee; Ji Young Yoo; Sung Taek Jung; Dae-Geun Jeon
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Using epidemiology and genomics to understand osteosarcoma etiology.

Authors:  Sharon A Savage; Lisa Mirabello
Journal:  Sarcoma       Date:  2011-03-08

9.  The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.

Authors:  Yusuke Tsuda; Koichi Ogura; Yusuke Shinoda; Hiroshi Kobayashi; Sakae Tanaka; Akira Kawai
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

10.  Chemotherapy in primary osteogenic sarcoma in patients over the age of forty.

Authors:  Bulent Ozkurt; Kerem Basarir; Bulent Yalcin; Abdullah Merter; Yusuf Yildiz; Yener Saglik
Journal:  Acta Orthop Traumatol Turc       Date:  2017-02-16       Impact factor: 1.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.